Literature DB >> 9924165

Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation.

G C Flaker1, D J McGowan, M Boechler, G Fortune, B Gage.   

Abstract

BACKGROUND: Antithrombotic agents are underutilized in elderly patients with atrial fibrillation. In a peer-review audit of antithrombotic use in Missouri, rural patients were given antithrombotic therapy less often than rural patients for unclear reasons. METHODS AND
RESULTS: The charts of 597 hospitalized Medicare patients discharged between October 1, 1993, and December 31, 1994, from urban and rural hospitals in Missouri were reviewed. In addition to antithrombotic therapy prescribed at the time of discharge, patient and physician information, relative contraindications to antithrombotic therapy, and risk factors for stroke were identified. Rural and urban patients were similar in terms of age, sex, and risk factors for stroke. At least one stroke risk factor was noted in 87% of rural patients and in 84% of urban patients. Urban patients were more likely to have a relative contraindication to antithrombotic therapy compared with rural patients (66% vs 54%, P =.04) but received antithrombotic therapy more often (58% vs 47%, P =.02). Cardiologists prescribed antithrombotic therapy significantly more often than noncardiologists (69% vs 52%, P =.003).
CONCLUSIONS: Elderly rural patients with atrial fibrillation receive antithrombotic therapy less frequently than urban patients despite having a similar high-risk profile and fewer relative contraindications. Primary care physicians prescribe antithrombotic therapy less often than cardiologists, which is one of the reasons for this underutilization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9924165     DOI: 10.1053/hj.1999.v137.91403

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  Anticoagulation to prevent stroke in atrial fibrillation. It's still not clear whether results in secondary care translate to primary care.

Authors:  D A Fitzmaurice; J Mant; E T Murray; F D Hobbs
Journal:  BMJ       Date:  2000-11-04

Review 2.  Why is warfarin underutilized in patients with atrial fibrillation?

Authors:  Greg C Flaker; John Schutz
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

Review 3.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

4.  Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation.

Authors:  Benjamin A Steinberg; Melissa A Greiner; Bradley G Hammill; Lesley H Curtis; Emelia J Benjamin; Susan R Heckbert; Jonathan P Piccini
Journal:  Cardiovasc Ther       Date:  2015-08       Impact factor: 3.023

Review 5.  A systematic review of validated methods for identifying atrial fibrillation using administrative data.

Authors:  Paul N Jensen; Karin Johnson; James Floyd; Susan R Heckbert; Ryan Carnahan; Sascha Dublin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

6.  A practical approach to the management of patients with atrial fibrillation.

Authors:  Christopher J McLeod; Bernard J Gersh
Journal:  Heart Asia       Date:  2010-09-06

Review 7.  Pharmacological Therapy in Stroke Prophylaxis - The New versus the Old Agents.

Authors:  Abhishek Maan; E Kevin Heist; Jeremy N Ruskin; Moussa Mansour
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 8.  Anticoagulants for atrial fibrillation: why is the treatment rate so low?

Authors:  Thomas A Buckingham; Robert Hatala
Journal:  Clin Cardiol       Date:  2002-10       Impact factor: 2.882

Review 9.  Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials?

Authors:  Rik Willems; Derek V Exner
Journal:  J Interv Card Electrophysiol       Date:  2004       Impact factor: 1.900

10.  Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy.

Authors:  D Ferro; L Loffredo; L Polimeni; F Violi
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.